odronextamab
regeneron,regeneron
['lymphoma', 'odronextamab', 'follicular', 'regeneron']
giving researchers a first look at interim results from its phase ii study of its drug odronextamab at #ash22, regeneron claims it has set a 'new benchmark' in follicular lymphoma. 
The biopharma world is here. Get the industry’s most comprehensive daily news reports at https://t.co/qpcDlbaOSx